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Aortic arch and common carotid artery plaques
with soft components pose a substantial risk of
cerebral embolization during carotid stenting
Pe´ter Szikra1, Erika Vo¨ro¨s1, Krisztina Boda2, Ferenc Rarosi2, Attila Thury3,
Pa´l Barzo´4 and Tama´s Ne´meth4
Abstract
Objectives: A higher rate of embolization is considered a disadvantage of carotid stenting (CAS), when compared with
carotid endarterectomy. Plaques in the aortic arch (AA) and the common carotid artery (CCA) may be additional sources of
embolization to stented internal carotid plaques during CAS. In this study, we aimed to investigate the relationship between
these plaques and intracerebral embolization.
Methods: We analyzed the occurrence and composition of plaques in the AA and CCA by computed tomography angiography
(CTA) in 101 consecutive cases of CAS. Cases of peri-procedural embolization were detected on diffusion-weighted imaging
as lesions demonstrating diffusion restriction. We applied the 2 and Fisher’s exact tests, as well as logistic regression
models.
Results: The occurrence of plaques in the AA and CCA was significantly related to the appearance of new diffusion-weighted
imaging lesions (p¼ 0.013 and p¼ 0.004, respectively). Patients with soft plaques in the AA or CCA had a significantly higher
risk of embolization than those without plaques (p¼ 0.012 and p¼ 0.006, respectively). In contrast, homogeneously calcified
plaques did not pose significantly higher risks.
Conclusions: Soft plaques in the AA and CCA result in a substantial risk of embolization during CAS. Use of a CTA exam-
ination of the AA and the CCA in patients with carotid stenosis may help to select lower-risk patients for CAS.
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Introduction
When carotid artery stenting (CAS) is carried out by an
experienced interventionalist, it is equivalent to carotid
endarterectomy (CEA) performed by an experienced
surgeon.1 Recent comparative studies have shown
that CAS and CEA are associated with similar cumu-
lative morbidity and mortality rates; however, while
peri-procedural embolization is more frequent in stent-
ing, surgery carries a higher risk for acute myocardial
infarction, surgical infection and complications of
anaesthesia.1,2
Reducing the risk of peri-procedural embolization
related to CAS might increase its applicability, con-
sidering that this technique can be carried out without
anesthesia. After CAS, fresh ischemic lesions frequently
occur, not only in areas supplied by the vessel affected
by CAS treatment, but also on the contralateral side
and in the posterior fossa. The appearance of these
lesions cannot be attributed to the stented plaque.3
Ulcerated plaques of the aortic arch (AA) have an
important role in the development of ischemic stroke
as a source of embolization.4 Therefore, development
of fresh ischemic lesions in the course of CAS is unli-
kely to be explained by the presence of only internal
1Department of Radiology, Medical University Center, University of Szed,
Szeged, Hungary
2Department of Medical Physics and Informatics, Medical University Center,
University of Szed, Szeged, Hungary
3Department of Cardiology, Medical University Center, University of Szged,
Szeged, Hungary
4Department of Neurosurgery, University of Szeged, Medical University
Center, Szeged, Hungary
Corresponding author:
Pe´ter Szikra, Department of Radiology, Medical University Center, University
of Szeged, Semmelweis u., 6, H-6725, Szeged, Hungary.
Email: peterszikra70@gmail.com
Interventional Neuroradiology
0(00) 1–8
! The Author(s) 2016
Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/1591019916633242
ine.sagepub.com
carotid artery (ICA) plaques, and other factors must
also be taken into account.3
Computed tomographic angiography (CTA) is a
suitable and accepted imaging method for the examin-
ation of atherosclerotic plaques regarding spatial pos-
ition and composition. This technique even enables the
mapping of sections of vessels that are not accessible by
ultrasound.5–10 Diffusion-weighted imaging (DWI) is
used to locate the positions of new ischemic lesions
resulting from intervention, and assesses their sizes
(i.e. the consequences of dislodged emboli by the
manipulation of catheters).11–14
In this study, we examined whether there are rela-
tionships between AA and common carotid artery
(CCA) plaques in the development of fresh ischemic
lesions. We also examined whether the composition of
plaques affected the degree of embolization. The results
of our study were expected to help select patients with
carotid stenosis in whom the application of the endo-
vascular technique is accompanied by a low risk of
embolization and thus, for whom stenting may be
recommended.
Materials and methods
This study was conducted with the approval of the
Board of Ethics of the University of Szeged’s Medical
University Centre. All of the patients were fully
informed about the study and provided written consent.
Between June 2010 and December 2012, a total of
101 consecutive cases involving 92 patients with symp-
tomatic carotid stenosis (40 women and 52 men; mean
age 64.8 8.2 years) were examined retrospectively at
our institution (Table 1).
The length and stenotic rate of the stenotic segment
were manually calculated on the basis of digital subtrac-
tion angiography, according to criteria from the North
American Symptomatic Carotid Endarterectomy Trial.15
The CTA procedure was carried out with a 64-slice
scanner (GE Light Speed VCT, General Electric
Healthcare, Fairfield, CT, USA) in accordance with
the following protocol:
. Helical mode, gantry rotation: 0.4 s;
. Collimation: 62 0.625mm;
. Pitch: 0.984:1;
. Section thickness: 0.625mm;
. Reconstruction interval: 0.5mm; and
. Acquisition parameters: 120 kV/50–600 mA.
The examination was carried out in the caudocranial
direction, from the middle of the chest up to the vertex.
A volume of 50–70ml of contrast medium (Omnipaque
350, General Electric Healthcare, Fairfield, CT, USA)
was injected through the antecubital vein with an injec-
tor, at a rate of 2.5–4mL/s. The test bolus technique
was applied to optimize the timing of the CTA.
Measurements of stenosis were taken with the
Advantage Windows 4.4 (General Electric) workstation
using the Advanced Vessel Analysis program, based on
a decrease in the cross-sectional area.
CTA images showed the presence or absence of
plaques in the AA and CCA – brachiocephalic artery
areas. Two groups of plaques were distinguished:
The purely calcified and the partly or purely soft pla-
ques. In most cases, proper window use (our settings
were window width 500–900 HU and window level
100–250 HU) enabled the calcified and soft plaques to
be distinguished by visual assessment.9 When the
material of the plaque was in doubt, its density was
measured. Plaques with a density over 241 HU were
regarded as calcified; while those below 240 HU6,8
were regarded as soft. We performed the density meas-
urements on the source images, with the Measure pro-
gram viewer and display tools of Advantage Windows
4.4 (General Electric Healthcare).
CAS was carried out under double thrombocyte
aggregation protection (aspirin 300mg/d and clopido-
grel 75mg/d), that were started at least 3 days before
endovascular intervention.16 At the start of the inter-
vention, 70 U/kg heparin was administered in a bolus.
Whenever significant bradycardia or asystolia was
noted during the post-dilation phase, the required
amount of atropine was injected.
Only the vessels that were affected by stenosis were
selectively examined with catheter angiography. As a
first choice, we used the head-hunter 1 type, and in
the case of a failed attempt, the Simmons 1, 2 or 3
type 4F catheter (Cordis, Johnson and Johnson, East
Bridgewater, NJ, USA), introduced by a 03500 Standard
Glidewire (Terumo, Somerset, NJ, USA) guide wire. In
the case of any difficult morphological situation, we
used a 03500  260 replacement wire, the Emerald
guide wire (Cordis). For pre-dilation and post-dilation,
we used a 0.01400 4 20mm and 6 20mm Aviator
Plus (Cordis) balloon catheter, respectively. No
embolic protection device (EPD) was used in the inter-
ventions. Two types of closed-cell stents were
implanted: The Carotid Wallstent (Boston Scientific,
Natick, MA, USA) and the Xact Carotid Stent
(Abbott Laboratories, Abbott Park, IL, USA).
All stent procedures were done under local anesthe-
sia, with monitoring by an anesthesiologist. All stenting
procedures were performed by the same neuroradiolo-
gist, with experience in > 800 carotid stenting
Table 1. Patient demography.
Case number 101
Patient number 92
Mean age/year 64.8 8.2
Female gender 40 43.50%
Male gender 52 56.50%
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procedures. Transfemoral arterial approaches were per-
formed in all cases. We did a diagnostic angiogram of
the common carotid artery in question, to confirm the
presence of significant stenosis and to make the final
decision to do the interventional procedure. All stents
were post-dilated to not less than 90% of the measured
diameter of the normal ICA. Finally, angiograms of the
carotid bifurcation and the intracranial circulation were
performed, to demonstrate the reconstruction of the
carotid lumen and to exclude macroembolic complica-
tions. After the procedure, the patients were monitored
in a neurologic intermediate care unit for 24 hours.
New ischemic lesions were detected with DWI and
the apparent diffusion coefficient (ADC) mapping was
performed the GE Signa Excite HDxT, 1,5T (General
Electric) and Advantages Windows 4.4 workstation),
within 48 h of the intervention. DWI was acquired
with an echo-planar axial sequence as follows:
. Repetition time: 8000ms;
. Echo time: minimum 97.6ms;
. Matrix: 128 128 matrix;
. FOV: 260 260mm;
. Slice thickness: 5mm without a gap; and
. Choosing b values of 0 and 1000 s/mm2.
An ADC map was generated with the Functool pro-
gram on the Advantage Windows workstation in each
case. Areas showing restricted diffusion of a high signal
on DWI and a low signal on an ADC map were identi-
fied as new ischemic lesions. Depending on localization,
lesions were assigned to three groups: ipsilateral,
contralateral and posterior fossa. The lesions were
grouped by size (<10mm, 10–20mm and> 20mm).
The observer analyzing CTA was blinded to the results
of DWI. The CTA, DWI examinations and stenting
procedure were always carried out by the same neuror-
adiologist, who is a professional with 20 years of
experience.
The period between the first femoral puncture and
the end of the first 48 h following revascularization was
regarded as the peri-procedural period of the interven-
tion (Figure 1).
Statistical methods
Patients with plaques in the AA and CCA were com-
pared with those without such plaques, to determine
which group had more chance of developing new ische-
mic lesions. The relationships between the occurrence
of plaques and new ischemic lesions was analyzed with
the 2 test and Fisher’s exact test. Logistic regression
models were applied for assessing the effect of the risk
factors. The effect of the composition of plaques in the
AA and CCA on the risk of appearance of new ische-
mic lesions was measured by ORs. Additionally, 95%
CI for the ORs were calculated. P values< 0.05 were
regarded as statistically significant. The statistical
analysis was carried out with SPSS 22 software (IBM
SPSS Statistics for Windows, Version 22.0.)
Results
All 101 carotid stenoses were successfully treated with
endovascular treatment. Two cases developed clinical
signs of peri-procedural ischemic stroke (modified
Rankin Scale 2 and 3). New ischemic lesions were
found in 50% of all cases (50/101). In 19% (19/101)
of the cases, only one new ischemic lesion occurred.
The sizes of new ischemic lesions did not exceed
10mm in 90.8% of cases. Therefore, those lesions
exceeding 10mm were not studied as a separate
group. The average procedure time was 58.8 (35–115)
minutes. The average procedure time of patients with-
out a new DWI lesion was shorter (57.2 minutes), while
the procedure time of the cases with new DWI lesions
was numerically longer only (60.32 minute). The differ-
ence was not significant. In 12% (12/101) of the failed
attempts at entering via the first choice diagnostic cath-
eter, a second diagnostic catheter was used. New DWI
lesions were identified in 75% (9/12) of these cases. A
total of 76% (38/50) of these new lesions occurred in
areas that were supplied by vessels affected by the treat-
ment (ipsilateral side). A total of 24% of the new
lesions (12/50) were not related to the treated stenotic
lesion (contralateral side and/or posterior fossa).
In 42% (21/50) of the cases where new ischemic lesions
were present, embolization occurred on the ipsilateral
side and on the contralateral side and/or the posterior
fossa.
The incidence of new ischemic lesions was statistic-
ally not independent of whether the AA was covered by
plaques. A significant (p¼ 0.013) relationship was
found between the occurrence of plaques covering the
AA and the incidence of new ischemic lesions. Where
the AA plaque was purely calcified, the occurrence of a
plaque resulted in a 2.311 times higher risk (OR) of
embolization, compared with plaque-free cases; but
this increase was not significant (p¼ 0.28; 95% CI
0.505–10.573). For patients with plaques containing
soft components, the increase in risk was 5.617 times,
compared with plaque-free cases (p¼ 0.012; 95% CI
1.453–21.713) (Table 2).
When comparing cases of purely calcified plaques in
the AA with those containing soft components, the OR
for the risk of developing new ischemic lesions was
2.431; however, this result was significant only at a sig-
nificance level of 10% (p¼ 0.08).
The incidence of new ischemic lesions was statistic-
ally not independent of whether the CCA was covered
by plaques. A significant (p¼ 0.004) relationship was
found between the plaques covering the CCA and the
incidence of new lesions. If the plaques in the CCA
were purely calcified, they did not cause any further
increase in risk (OR 0.812), compared with patients
with no plaques (p¼ 0.67; 95% CI 0.3135–2.111).
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When the CCA plaque contained soft components, the
risk of incidence of new ischemic lesions was 4.411
times higher, as compared with patients without pla-
ques (p¼ 0.006; 95% CI 1.517–12.822), as seen in
Table 3.
When comparing purely calcified plaques in the
CCA with those containing soft components, the OR
for the risk of developing new ischemic lesions was
5.429 (p¼ 0.003). When the patient represented both
AA and CCA plaque that contained soft components,
Figure 1. A 50 year-old female patient had significant ICA stenosis on the right side before (a) and after (b) stenting. Extensive soft
plaques with some calcified components were observed on the primary AA slices (c). ADC (d) and DWI (e) images demonstrate several
fresh ischemic lesions on the contralateral side. Some new lesions were found on the ipsilateral side (not seen) and posterior fossa.
AA: aortic arch; ADC: apparent diffusion coefficient; DWI: diffusion-weighted imaging; ICA: internal carotid artery
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the risk of incidence of new ischemic lesions was 7.037
times higher, as compared with patients without pla-
ques (p¼ 0.0003; 95% CI 2.364–20.944).
Discussion
In the current study, we found new ischemic lesions in
50% of all CAS cases that we detected. This rate is
higher than that in cases of CEA treatment (24–34%);
but it is similar to previous results of CAS treatment,
despite the use of embolic protection device
(38–67%).12,17–20 We found that not all new ischemic
lesions can be regarded as related to the area of the
vessel that has undergone treatment, because lesions
were also found in 24% of cases on the contralateral
side and/or in the posterior fossa. These findings corres-
pond well with those observed in previous clinical
studies.2,21,22
Yoshimura et al.4 identified ulcerated plaques in the
AA as a source of embolization that could be related to
the development of ischemic strokes. The findings of
Kim et al.3 suggest that maneuvers in the AA during
CAS play an important role in the occurrence of new
ischemic lesions in the posterior fossa and contralateral
ICA territory. There is a difference between purely cal-
cified plaques and those containing soft components in
their potential to produce emboli. Therefore, the com-
position of plaques can be a factor involved in cases
with plaques in the AA and CCA.11,23–27 No EPD was
used in the interventions: At present there is no avail-
able level 1 evidence to support the routine use of
EPDs.28–31 While during part of the peri-procedural
phase an EPD may provide partial protection of the
ICA to be treated, it does not provide protection
against contralateral or posterior fossa embolization
originating from the plaques of the AA on which our
study was focused. Unfortunately, at present we have
no device restricting embolization that could provide
protection during diagnostic catheter use or the intro-
duction of the thickest endovascular device, a guiding
catheter, for both the vessel area that is to be treated
and for the areas subject to embolization by the AA
and CCA plaques.
We used CTA to distinguish calcified plaques from
soft plaques, based on density.5–10 We did not investi-
gate soft plaques further. This is because according to
studies by Wintermark et al.6 and De Weert et al.8 the
density values of the soft components, such as necrotic
tissue, other tissues rich in lipids, connective tissue and
plaque hemorrhage show considerable overlap.
Therefore, they are collectively referred to as a ‘soft
plaque’.6,8 For detecting new ischemic lesions, we
applied the internationally accepted method of
DWI.11–14 Most areas of restricted diffusion cause no
neurological symptoms (i.e. they are functionally silent
ischemic areas).3 In our study, although new ischemic
lesions were detected in 50% of all cases, only 2% of
these DWI lesions were found to be symptomatic; how-
ever, many studies have shown an association between
new asymptomatic ischemic lesions and worsening
results of neuropsychological tests.13,32 Gensicke
et al.33 showed that ischemic brain lesions discovered
on DWI after CAS appear to be a marker of increased
risk for recurrent cerebrovascular events. Therefore,
minimizing the risk of embolization should be a
priority.
In our study, we found that there was a relationship
between the presence of AA plaques and development
of fresh ischemic lesions. Embolization in an area other
than that supplied by the stented ICA occurred in 24%
Table 2. Logistic regression analysis (with CI) of assessment of AA plaque components as risk factors.
Plaques
Lesion-free
cases (n/%)
DWI lesion
cases (n/%)
Total cases
(n/100%) p-value OR 95% CI
Reference category (n) 13/81.3 3/18.8 16 0.019 – –
Calcified 15/65.2 8/34.8 23 0.28 2.311 0.505–10.573
Soft 27/43.5 35/56.5 62 0.012 5.617 1.453–21.714
Total 55/54.5 46/45.5 101
AA: aortic artery; DWI: diffusion-weighted imaging
Table 3. Logistic regression analysis (with CI) of assessment of CCA plaque components as risk factors.
Plaques
Lesion-free
cases (n/%)
DWI lesion
cases (n/%)
Total cases
(n/100%) p-value OR 95% CI
Reference
category (n)
26/61.9 16/38.1 42 0.007 – –
Calcified 22/66.7 11/33.3 33 0.67 0.812 0.313–2.111
Soft 7/26.9 19/73.1 26 0.006 4.411 1.517–12.822
Total 55/54.5 46/45.5 101
CCA: common carotid artery; DWI: diffusion-weighted imaging
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of all cases, which is slightly less than the results of a
similar study of 32 patients (41%)3; however, this find-
ing emphasizes the need to further investigate the
potential of plaques in the AA to produce emboli.
In our study, not all of the patients whom received
CAS treatment had plaques in the AA or CCA. In cases
where no plaques were present in the AA, we did not
encounter any new lesions outside the territory supplied
by the vessel in question. This lack of finding confirms
our notion of new contralateral and posterior fossa
ischemic lesions originating in the AA. AA and CCA
plaques significantly increased the risk of development
of new ischemic lesions, compared with cases where AA
and CCA plaques were not present. In cases where the
AA plaque was purely calcified, no significant differ-
ence in the incidence of new ischemic lesions was
detected. When patients with purely calcified AA pla-
ques were directly compared with those who had pla-
ques with soft components, the risk of developing new
ischemic lesions was not significant (p¼ 0.08). The lack
of significance is thought to be due to the moderate
sample size. We found that there was a relationship
between the presence of CCA plaques and the develop-
ment of fresh ischemic lesions. When patients with
purely calcified CCA plaques were compared with
those with plaques with soft components, the risk of
developing new ischemic lesions was significant. These
results suggested that plaques with soft components
in the AA and CCA had an increased risk of peri-
procedural embolization. Use of a smaller, more
properly-shaped device in the AA decreases the mobil-
ization of atheromas.3 One of the reasons for patients
suffering an embolism during intervention is related to
manipulation of the catheter during the procedure.
The AA and CCA form part of the intervention
route that is used in the course of ICA stenting,
where the guide wires and catheters come into contact
with and mechanically insult the vessel walls with pla-
ques on them. Therefore, both of these areas are
assumed to increase the rate of complications of embol-
ization in CAS. While plaques in the AA can also affect
the contralateral side and the posterior fossa, plaques in
the CCA can only affect the ipsilateral side, because of
anatomical reasons; however, it should be noted that
the use of an inflated flow reversal EPD in a plaque-
covered CCA raises questions, in view of the results of
this study. The CCA plaque definitely deserves to be
studied in the case of the most up-to-date flow reversal
devices inserted directly into the common carotid
artery, the Silkroad system (Silkroad Medical,
Sunnyvale, CA), where a small incision is performed
on the CCA and the loop is placed to clamp the artery.
Even when using 4F soft diagnostic catheters, a
neurological complication rate of 1.3% should be
expected, as shown by a prospective study of diagnostic
cerebral angiograms of 2899 patients.34 The interven-
tionalists navigate instruments by rotating and pushing
forward, and by withdrawing the guide wire and a
5–8F-diameter catheter towards the ICA stenosis.
The catheter always rests on the inside surface of the
vessel wall, where it exerts some force, depending on the
morphology of the vessel and flexibility of the catheter
on the point that supports them. The force exerted on
the points supporting the catheter increases as a result
of the changes in vessel morphology and a decrease in
the radius of its bends.35
New peri-procedural ischemic lesions appearing on
the contralateral side or in the posterior fossa are highly
likely to be the consequence of manipulations of the
catheter in the AA.3 Therefore, extending CTA map-
ping to the AA is important. CTA mapping of potential
embolized plaques to decrease the complications
of embolization in patients may help make catheter
therapy a safer treatment, even if there are plaques in
the AA.9
Conclusions
Soft plaques in the AA and CCA significantly increase
peri-procedural embolization in treatment-related and
non-treatment-related locations; however, in cases
where purely calcified plaques or no plaques are pre-
sent, performing endovascular procedures in the ICA
did not result in any increase in risk. Use of a CTA
examination of the AA and the CCA in patients with
carotid stenosis may help to select lower-risk patients
for CAS. One of the limitations of this study was that it
is a retrospective one; therefore, more patients should
be involved in future studies in order to produce more
detailed results.
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